REGENERON PHARMACEUTICALS, INC. Common Stock Shares Outstanding

Quick Answer

REGENERON PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 90.69 million shares for the year ending 2011.

  • REGENERON PHARMACEUTICALS, INC. showed an increase of +4.0% in Common Stock Shares Outstanding from 2010 to 2011.
  • This data is from REGENERON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 21, 2012.
  • XBRL data for this metric is available from 2009 to 2011 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2010: 79.92 million shares | Q3 2010: 80.04 million shares | Q1 2011: 88.55 million shares | Q2 2011: 89.42 million shares | Q3 2011: 90.42 million shares | Q4 2011: 90.69 million shares | Q1 2012: 92.97 billion shares | Q2 2012: 93.94 billion shares | Q3 2012: 94.41 million shares.
  • Over the full 3 years of available data (2009 to 2011), REGENERON PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 15.0%.
  • Historical annual values: Fiscal year 2011: 90.69 million shares | Fiscal year 2010: 87.24 million shares | Fiscal year 2009: 78.86 million shares.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: